Oxagen, Cerylid Team Up to Study Genetics of Endometriosis | GenomeWeb

NEW YORK, Aug 29 – Oxagen of Abingdon, UK, and Cerylid Biosciences of Melbourne, said Wednesday that they had agreed to collaborate to jointly study the genetic basis of endometriosis. 

Oxagen and Cerylid are planning to look for genes and SNPs that lead to endometriosis and to eventually find targets that will lead to new diagnostics and treatments for the disease, which is estimated to affect as many as 10 percent of women of reproductive age, the companies said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.